In such a variegated scenario, where two widespread diseases, cancer and COVID-19, continue to alarm, we decided to provide a critical focus on the molecular aspects dissecting Nrf2 dual role and summarize in an updated review the most recent findings about the advantages of Nrf2 activation or inhibition in both diseases. Here, NFE2L2 is linked to COVID-19.